Lian et al., 2016 - Google Patents
Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's diseaseLian et al., 2016
View PDF- Document ID
- 13193184898149077176
- Author
- Lian H
- Zheng H
- Publication year
- Publication venue
- Journal of neurochemistry
External Links
Snippet
Astrocytes are the most abundant cells in the central nervous system. They play critical roles in neuronal homeostasis through their physical properties and neuron–glia signaling pathways. Astrocytes become reactive in response to neuronal injury and this process …
- 206010001897 Alzheimer's disease 0 title abstract description 58
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lian et al. | Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease | |
| Andoh et al. | Microglia regulate synaptic development and plasticity | |
| Wang et al. | Deficiency in BDNF/TrkB neurotrophic activity stimulates δ-secretase by upregulating C/EBPβ in Alzheimer’s disease | |
| Dubal et al. | Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice | |
| Hemonnot et al. | Microglia in Alzheimer disease: well-known targets and new opportunities | |
| Xiang et al. | The role of endoplasmic reticulum stress in neurodegenerative disease | |
| Oksanen et al. | PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in Alzheimer's disease | |
| Spangenberg et al. | Inflammation in Alzheimer’s disease: lessons learned from microglia-depletion models | |
| Minter et al. | The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease | |
| Tincer et al. | Focus: The aging brain: neural stem/progenitor cells in Alzheimer’s disease | |
| Wolfe | The role of tau in neurodegenerative diseases and its potential as a therapeutic target | |
| Quan et al. | Ginsenoside Rg1 decreases Aβ1–42 level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease | |
| Zhang et al. | Inflammation in Alzheimer’s disease and molecular genetics: recent update | |
| Konishi et al. | Phagocytic astrocytes: emerging from the shadows of microglia | |
| Shi et al. | Complement C3-deficient mice fail to display age-related hippocampal decline | |
| Tóth et al. | Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice | |
| Chang et al. | Untangling the Tauopathy for Alzheimer’s disease and parkinsonism | |
| Cai et al. | Physiological roles of β-amyloid in regulating synaptic function: Implications for AD pathophysiology | |
| Guedes et al. | Microglia‐dependent remodeling of neuronal circuits | |
| Cenini et al. | Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models | |
| Zhong et al. | Lipid transporter Spns2 promotes microglia pro‐inflammatory activation in response to amyloid‐beta peptide | |
| Cudaback et al. | APOE genotype‐dependent modulation of astrocyte chemokine CCL3 production | |
| Werner et al. | Parkinson's disease modification through Abl kinase inhibition: an opportunity | |
| Quan et al. | CDK5 participates in amyloid-β production by regulating PPARγ phosphorylation in primary rat hippocampal neurons | |
| Ridolfi et al. | The role of the innate immune system in Alzheimer’s disease and frontotemporal lobar degeneration: an eye on microglia |